Clinical case of secondary dilated cardiomyopathy after primary myocarditis

Abstract

The article describes a clinical case of secondary dilated cardiomyopathy after viral hepatitis B. Pharmacotherapy remains the main method of DCMP treatment regardless of the etiology of the disease and the use of specific treatment methods (anti-inflammatory, anti-infective and immunomodulatory therapy) as well as treatment of chronic heart failure with the main groups of drugs such as: angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, β-adrenoblockers, diuretics, aldosterone receptor antagonists, cardiac glucosides. Also surgical corrections are used: prosthesis and plasty of the mitral valve, reconstruction of atria and splenic arteries, implantation of diastolic and intermittent devices, biventricular stimulation. However, the radical method of treatment of patients suffering from DCMP with a temporary stage of cardiac insufficiency refractory to therapy is still a heart transplantation.